KRW 20500.0
(2.5%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 82.98 Billion KRW | 28.03% |
2022 | 63.65 Billion KRW | 82.27% |
2021 | 34.92 Billion KRW | 59.77% |
2020 | 21.86 Billion KRW | 25.13% |
2019 | 17.46 Billion KRW | 312.95% |
2018 | 4.23 Billion KRW | 60.94% |
2017 | 2.62 Billion KRW | -49.76% |
2016 | 5.23 Billion KRW | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 21.42 Billion KRW | 10.2% |
2024 Q2 | 21.75 Billion KRW | 1.54% |
2023 Q3 | 20.34 Billion KRW | -8.69% |
2023 FY | 81.5 Billion KRW | 28.03% |
2023 Q4 | 19.44 Billion KRW | -4.42% |
2023 Q2 | 22.27 Billion KRW | 14.6% |
2023 Q1 | 19.43 Billion KRW | -27.01% |
2022 FY | 63.65 Billion KRW | 82.27% |
2022 Q1 | 10.38 Billion KRW | 17.23% |
2022 Q4 | 26.63 Billion KRW | 78.09% |
2022 Q3 | 14.95 Billion KRW | 26.8% |
2022 Q2 | 11.79 Billion KRW | 13.6% |
2021 Q3 | 10.24 Billion KRW | 0.0% |
2021 FY | 34.92 Billion KRW | 59.77% |
2021 Q4 | 8.85 Billion KRW | -13.53% |
2020 FY | 21.86 Billion KRW | 25.13% |
2019 FY | 17.46 Billion KRW | 312.95% |
2018 FY | 4.23 Billion KRW | 60.94% |
2017 FY | 2.62 Billion KRW | -49.76% |
2016 FY | 5.23 Billion KRW | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
CMG Pharmaceutical Co., Ltd. | 43.7 Billion KRW | -89.886% |
Celltrion Pharm, Inc. | 116.95 Billion KRW | 29.048% |
Huons Global Co., Ltd. | 417.8 Billion KRW | 80.138% |
DongKook Pharmaceutical Co., Ltd. | 405.04 Billion KRW | 79.512% |
Enzychem Lifesciences Corporation | 3.29 Billion KRW | -2419.675% |
Humedix Co., Ltd. | 68.04 Billion KRW | -21.957% |
Boditech Med Inc. | 76.7 Billion KRW | -8.188% |
EuBiologics Co., Ltd. | 32.65 Billion KRW | -154.096% |
FutureChem Co.,Ltd | 758.27 Million KRW | -10844.013% |
Huons Co., Ltd. | 285.93 Billion KRW | 70.978% |
BNC Korea Co., Ltd. | 31.97 Billion KRW | -159.507% |
AptaBio Therapeutics Inc. | 78.49 Million KRW | -105615.305% |